Full Text
Should Changes in Drug Price Over Time be Considered in Cost-Effectiveness Analyses?

Abstract

Authors

A. Millier B. Briquet S. Aballea M. Toumi

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×